8月4日 - ** 制药商Axsome Therapeutics AXSM.O股价盘前上涨5.9%至108.98美元
** 公司公布的第二季度营收为1.5亿美元，高于分析师预计的1.388亿美元。
** 称第二季度抑郁症药物 Auvelity 的销售额为 1.196 亿美元，比去年同期的 6500 万美元增长 84
** 报告第二季度每股净亏损 97 美分，低于去年同期的每股亏损 1.67 美元
** 截至收盘，股价累计上涨 21.8
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.